Correlation Between Tarsus Pharmaceuticals and Inventiva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Inventiva Sa, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Inventiva.

Diversification Opportunities for Tarsus Pharmaceuticals and Inventiva

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tarsus and Inventiva is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Inventiva go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Inventiva

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.44 times more return on investment than Inventiva. However, Tarsus Pharmaceuticals is 1.44 times more volatile than Inventiva Sa. It trades about 0.22 of its potential returns per unit of risk. Inventiva Sa is currently generating about -0.06 per unit of risk. If you would invest  4,473  in Tarsus Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  611.00  from holding Tarsus Pharmaceuticals or generate 13.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Inventiva Sa

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Inventiva Sa 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inventiva Sa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Inventiva sustained solid returns over the last few months and may actually be approaching a breakup point.

Tarsus Pharmaceuticals and Inventiva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Inventiva

The main advantage of trading using opposite Tarsus Pharmaceuticals and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.
The idea behind Tarsus Pharmaceuticals and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum